Evidence map›Paper›PMID 31818964›Full record

ArticleInfection and immunity2020

Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.

Kirstie M Mangas, Andrew H Buultjens, Jessica L Porter, Sarah L Baines, Estelle Marion, Laurent Marsollier, Nicholas J Tobias, Sacha J Pidot, Kylie M Quinn, David J Price and 5 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Kirstie M MangasDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Andrew H BuultjensDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Jessica L PorterDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Sarah L BainesDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Estelle MarionCRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Laurent MarsollierCRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Nicholas J TobiasMolekulare Biotechnologie, Fachbereich Biowissenschaften, Goethe-Universität Frankfurt, Frankfurt am Main, Germany.
Sacha J PidotDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Kylie M QuinnMonash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
David J PriceVictorian Infectious Diseases Reference Laboratory Epidemiology Unit at The Peter Doherty Institute for Infection & Immunity, The University of Melbourne and Royal Melbourne Hospital, Parkville, Victoria, Australia.
Katherine KedzierskaDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Weiguang ZengDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
David C JacksonDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Brendon Y Chua *Department of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
Timothy P Stinear *Department of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia tstinear@unimelb.edu.au.ORCID 0000-0003-0150-123X
The University of Melbourne · AUInserm · FRAustralian Regenerative Medicine Institute · AUGoethe University Frankfurt · DEThe Royal Melbourne Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neglected tropical disease Buruli ulcer (BU) is an infection of subcutaneous tissue with

Indexed as

Buruli UlcerAnimalsBacterial VaccinesBCG VaccineInterleukinsMiceMultivariate AnalysisMycobacterium ulceransVaccinationBacterial VaccinesBCG VaccineInterleukinsBuruli ulcermachine learningMycobacterium ulceransmycolactonepolyketide synthasevaccine

Identifiers

PMID31818964
PMCPMC7035934
OpenAlexW2996311830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.